You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ELVN Sale Disclosure
Orbimed Advisors Llc · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$409.05K
Orbimed Advisors Llc 10% owner
ELVN
Enliven Therapeutics
ELVN
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
ELVN daily price context
Close on/before transaction
$42.36
Jun 15, 2026
First close after public filing
$45.1
Jun 18, 2026
30-day return after filing
+17.96%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,086 shares @ $45.02
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000947871-26-000637
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$12.67M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enliven Therapeutics, Inc. ELVN Current | Sale | Jun 15, 2026 | $409.05K |
| Enliven Therapeutics, Inc. ELVN | Sale | Jun 15, 2026 | $12.26M |